SCHEMBL25663113

SCHEMBL25663113

c1ccc2nnc(-c3ccc(N(c4ccc(-c5cc6ccccc6nn5)cc4)c4ccc(-c5ncnc6sc7ccccc7c56)cc4)cc3)cc2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ APP P05067 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663098 0.86 RAB9A (0.39) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663099 0.86 NPC1 (0.39) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663114 0.85 NPC1 (0.37) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663101 0.84 PIK3CA (0.48) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663108 0.84 NPC1 (0.40) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663123 0.84 APP (0.50) APPALDH1A1KMT2ALMNAMEN1
SCHEMBL25663254 0.82 NPC1 (0.46) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663109 0.82 TGFBR1 (0.39) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663259 0.82 PIK3CD (0.34) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663107 0.81 CYP1A2 (0.47) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 PIK3CD 4761/4885PIK3CA 4539/4885PIK3CB 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback